Are glucocortoids really deleterious to bone health?

Joint Bone Spine

Volumn 78, Issue , 2011, Pages S211-S213

  Roux, Christian ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bone densitometry; Fractures; Glucocorticoids; Osteoporosis; Rheumatic disorders

Indexed keywords

ANTIRHEUMATIC AGENT; GLUCOCORTICOID;

AGED; BONE DENSITY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EDITORIAL; FRAGILITY FRACTURE; HEALTH SURVEY; HUMAN; MALE; OSTEOLYSIS; OSTEOPOROSIS; PATHOLOGIC FRACTURE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE RESORPTION; FRACTURES, SPONTANEOUS; GLUCOCORTICOIDS; HUMANS; MALE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; POPULATION SURVEILLANCE; RISK ASSESSMENT;

EID: 84860253965     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/S1297-319X(11)70007-0     Document Type: Article

References (19)

1. David, C., Confavreux, C.B., Mehsen, N., et al. Severity of osteoporosis: what is the impact of co-morbidities?. Joint Bone Spine 77 (2010), S103–S106.
2. Paccou, J., Dewailly, J., Cortet, B., Reduced levels of serum IGF-1 is related to the presence of osteoporotic fractures in male idiopathic osteoporosis. Joint Bone Spine, 2011 Jul 29. [Epub ahead of print].
3. Guggenbuhl, P., Osteoporosis in males and females: is there really a difference?. Joint Bone Spine 76 (2009), 595–601.
4. van Staa, T.P., Geusens, P., Bijlsma, J.W., et al. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 54 (2006), 3104–3112.
5. Haugeberg, G., Uhlig, T., Falch, J.A., et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum 43 (2000), 522–530.
6. Ton, F.N., Gunawardene, S.C., Lee, H., et al. Effects of low-dose prednisone on bone metabolism. J Bone Miner Res 20 (2005), 464–470.
7. Laan, R.F., van Riel, P.L., van de Putte, L.B., et al. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 119 (1993), 963–968.
8. Kroot, E.J., Nieuwenhuizen, M.G., de Waal Malefijt, M.C., et al. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum 44 (2001), 1254–1260.
9. Gough, A.K., Lilley, J., Eyre, S., et al. Generalized bone loss in patients with early rheumatoid arthritis. Lancet 344 (1994), 23–27.
10. Schett, G., Kiechl, S., Weger, S., et al. High-sensitivity c-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med 166 (2006), 2495–2501.
11. Charatcharoenwitthaya, N., Khosla, S., Atkinson, E.J., et al. Effect of blockade of TNF–α and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22 (2007), 724–729.
12. Kong, Y.Y., Feige, U., Sarosi, I., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (1999), 304–309.
13. Sato, K., Suematsu, A., Okamoto, K., et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 203 (2006), 2673–2682.
14. Ghazi, M., Kolta, S., Briot, K., et al. Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int, 2011 Feb25[Epub ahead of print].
15. Güler-Yüksel, M., Allaart, C.F., Goekoop-Ruiterman, Y.P., et al. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 68 (2009), 330–336.
16. Chopin, F., Garnéro, P., le Henanff, A., et al. Long-term effects of infl iximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann Rheum Dis 67 (2008), 353–357.
17. Wijbrandts, C.A., Klaasen, R., Dijkgraaf, M.G., et al. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss. Ann Rheum Dis 68 (2009), 373–376.
18. Haugeberg, G., Strand, A., Kvien, T.K., et al. Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo controlled trial. Arch Intern Med 165 (2005), 1293–1297.
19. Roux, C., Osteoporosis in inflammatory joint diseases. Osteoporos Int 22 (2011), 421–433.